Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sultan Darvesh

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's diseaseDrew R DeBay, George A Reid, Ian R Pottie, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 12, 2012
Thioesters for the in vitro evaluation of agents to image brain cholinesterasesIan R Macdonald, Courtney T Jollymore, G Andrew Reid, et al.
ACS Chemical Neuroscience|July 11, 2012
Cysteine thioesters as myelin proteolipid protein analogues to examine the role of butyrylcholinesterase in myelin decompactionIan R Pottie, Emma A Higgins, Rachelle A Blackman, et al.
Neuroepidemiology|November 29, 2007
Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E statusKenneth Rockwood, Susan Howlett, John Fisk, et al.
Molecules (Basel, Switzerland)|November 30, 2017
Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric StudyTerrone L Rosenberry, Xavier Brazzolotto, Ian R Macdonald, et al.
Journal of Alzheimer'S Disease : JAD|April 29, 2017
Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's DiseaseIan R Macdonald, Selena P Maxwell, George A Reid, et al.
Molecular Imaging and Biology|May 28, 2026
Molecular Imaging of Butyrylcholinesterase Associated with Amyloid-β Plaques Distinguishes 5XFAD from Wild-Type Mice: A Proof-of-ConceptG Andrew Reid, Drew R DeBay, Ian R Macdonald, et al.
Bioorganic & Medicinal Chemistry|August 8, 2007
Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazineSultan Darvesh, Robert S McDonald, Katherine V Darvesh, et al.
Journal of Medicinal Chemistry|June 24, 2008
Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesteraseSultan Darvesh, Katherine V Darvesh, Robert S McDonald, et al.
Dementia and Geriatric Cognitive Disorders|August 25, 2010
An MRI-based semiquantitative index for the evaluation of brain atrophy and lesions in Alzheimer's disease, mild cognitive impairment and normal agingWei Chen, Xiaowei Song, Yunting Zhang, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's diseaseDrew R DeBay, George A Reid, Ian R Pottie, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 12, 2012
Thioesters for the in vitro evaluation of agents to image brain cholinesterasesIan R Macdonald, Courtney T Jollymore, G Andrew Reid, et al.
ACS Chemical Neuroscience|July 11, 2012
Cysteine thioesters as myelin proteolipid protein analogues to examine the role of butyrylcholinesterase in myelin decompactionIan R Pottie, Emma A Higgins, Rachelle A Blackman, et al.
Neuroepidemiology|November 29, 2007
Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E statusKenneth Rockwood, Susan Howlett, John Fisk, et al.
Molecules (Basel, Switzerland)|November 30, 2017
Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric StudyTerrone L Rosenberry, Xavier Brazzolotto, Ian R Macdonald, et al.
Journal of Alzheimer'S Disease : JAD|April 29, 2017
Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's DiseaseIan R Macdonald, Selena P Maxwell, George A Reid, et al.
Molecular Imaging and Biology|May 28, 2026
Molecular Imaging of Butyrylcholinesterase Associated with Amyloid-β Plaques Distinguishes 5XFAD from Wild-Type Mice: A Proof-of-ConceptG Andrew Reid, Drew R DeBay, Ian R Macdonald, et al.
Bioorganic & Medicinal Chemistry|August 8, 2007
Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazineSultan Darvesh, Robert S McDonald, Katherine V Darvesh, et al.
Journal of Medicinal Chemistry|June 24, 2008
Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesteraseSultan Darvesh, Katherine V Darvesh, Robert S McDonald, et al.
Dementia and Geriatric Cognitive Disorders|August 25, 2010
An MRI-based semiquantitative index for the evaluation of brain atrophy and lesions in Alzheimer's disease, mild cognitive impairment and normal agingWei Chen, Xiaowei Song, Yunting Zhang, et al.
Pageof 9